Position in ZYME
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$600,445,942
+$25,267,427 QoQ
Shares Held
22,970,388
0.0% QoQ
Ownership
32.4%
of shares outstanding
% of Portfolio
29.77%
of 13F equity value
Holder Rank
#1
of 203 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EcoR1 Capital, LLC holds $1,935,887,028 across 29 Biotechnology names. ZYME ranks #1 (31.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZYME |
Zymeworks Inc.
This page
|
22,970,388 | $600,445,942 | |
| 2 | ANAB |
Anaptysbio, Inc
|
7,880,094 | $531,906,345 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
4,824,469 | $155,492,635 | |
| 4 | CGON |
CG Oncology, Inc.
|
1,494,300 | $106,170,015 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
1,389,276 | $75,771,113 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
6,728,116 | $72,865,496 | |
| 7 | TRAX |
First Tracks Biotherapeutics, Inc.
|
3,174,519 | $63,871,322 | |
| 8 | LKFT |
Lakefront Biotherapeutics NV
|
1,667,119 | $49,980,227 |
All Filings in ZYME
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600,445,942 | 22,970,388 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $575,178,515 | 22,970,388 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $604,810,316 | 22,970,388 | Shares | Sole | 2026-02-17 | |
| 2025-11-16 | $425,411,585 | 22,970,388 | Shares | Sole | 2025-11-19 | |
| 2025-09-30 | $392,334,227 | 22,970,388 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $288,278,369 | 22,970,388 | Shares | Sole | 2025-08-14 | |
| 2025-06-26 | $284,143,699 | 22,970,388 | Shares | Sole | 2025-06-27 | |
| 2025-04-04 | $193,812,525 | 17,699,774 | Shares | Sole | 2025-04-08 | |
| 2025-03-31 | $205,561,216 | 17,259,548 | Shares | Sole | 2025-05-15 | |
| 2025-03-13 | $211,573,145 | 16,858,418 | Shares | Sole | 2025-03-17 | |
| 2025-02-17 | $235,959,616 | 15,720,161 | Shares | Sole | 2025-02-18 | |
| 2025-01-10 | $203,734,451 | 15,411,078 | Shares | Sole | 2025-01-13 | |
| 2024-12-31 | $220,011,076 | 15,028,079 | Shares | Sole | 2025-02-14 | |
| 2024-12-19 | $199,521,175 | 14,692,281 | Shares | Sole | 2024-12-23 | |
| 2024-09-30 | $168,640,286 | 13,437,473 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $114,352,895 | 13,437,473 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $141,362,215 | 13,437,473 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $139,615,344 | 13,437,473 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $85,193,578 | 13,437,473 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $116,099,766 | 13,437,473 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $91,190,755 | 10,087,473 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $59,488,983 | 7,568,573 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||